CGEM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,634,996.45

Cullinan Therapeutics Insider Trading History Chart

Cullinan Therapeutics Share Price & Price History

^$11.60

▲ +0.65 (5.94%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Cullinan Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2024	Jennifer Michaelson	Insider	Sell	4,693	$11.41	$53,547.13	99,760
12/12/2024	Jennifer Michaelson	Insider	Sell	3,489	$12.52	$43,682.28	104,453
11/5/2024	Jennifer Michaelson	Insider	Sell	8,000	$15.64	$125,120.00	107,942
9/5/2024	Jennifer Michaelson	Insider	Sell	8,000	$18.09	$144,720.00	115,942
7/5/2024	Jennifer Michaelson	Insider	Sell	8,000	$16.33	$130,640.00	123,942
5/6/2024	Jennifer Michaelson	Insider	Sell	58,000	$28.07	$1,628,060.00	129,582
2/1/2024	Corrine Savill	Insider	Sell	40,000	$16.18	$647,200.00	165,990
1/29/2024	Corrine Savill	Insider	Sell	40,000	$14.09	$563,600.00	165,990
1/22/2024	Corrine Savill	Insider	Sell	18,684	$12.14	$226,823.76	165,990
12/26/2023	Nadim Ahmed	CEO	Sell	4,272	$9.24	$39,473.28	111,550
12/21/2023	Jeffrey Alan Jones	Insider	Sell	1,860	$8.50	$15,810.00	56,191
12/21/2023	Jeffrey Trigilio	CFO	Sell	1,920	$8.50	$16,320.00	83,919
12/18/2023	Jeffrey Alan Jones	Insider	Sell	386	$8.22	$3,172.92	58,051
12/18/2023	Jeffrey Trigilio	CFO	Sell	398	$8.22	$3,271.56	85,839
12/12/2023	Jeffrey Trigilio	CFO	Sell	1,926	$7.81	$15,042.06	86,237
12/12/2023	Jennifer Michaelson	Insider	Sell	1,068	$7.81	$8,341.08	88,965
6/28/2023	Nadim Ahmed	CEO	Sell	759	$11.40	$8,652.60	115,822
6/20/2023	Jeffrey Alan Jones	Insider	Sell	387	$12.94	$5,007.78	58,437
6/20/2023	Jeffrey Trigilio	CFO	Sell	399	$12.94	$5,163.06	85,823
6/12/2023	Jeffrey Trigilio	CFO	Sell	319	$13.11	$4,182.09	86,222
6/12/2023	Jennifer Michaelson	Insider	Sell	176	$13.11	$2,307.36	90,271
6/6/2023	Jennifer Michaelson	Insider	Sell	11,900	$12.31	$146,489.00	90,447
5/23/2023	Nadim Ahmed	CEO	Sell	707	$9.15	$6,469.05	116,581
5/18/2023	Jeffrey Trigilio	CFO	Sell	399	$8.76	$3,495.24	86,541
5/18/2023	Jennifer Michaelson	Insider	Sell	239	$8.76	$2,093.64	90,447
5/12/2023	Jeffrey Trigilio	CFO	Sell	347	$8.78	$3,046.66	86,940
5/12/2023	Jennifer Michaelson	Insider	Sell	193	$8.78	$1,694.54	90,686
4/25/2023	Nadim Ahmed	CEO	Sell	716	$10.59	$7,582.44	117,288
4/18/2023	Jeffrey Alan Jones	Insider	Sell	392	$10.71	$4,198.32	59,218
4/18/2023	Jeffrey Trigilio	CFO	Sell	398	$10.71	$4,262.58	87,287
4/12/2023	Jeffrey Trigilio	CFO	Sell	318	$10.22	$3,249.96	87,685
4/12/2023	Jennifer Michaelson	Insider	Sell	176	$10.22	$1,798.72	91,117
3/23/2023	Nadim Ahmed	CEO	Sell	706	$10.51	$7,420.06	118,004
3/20/2023	Jeffrey Alan Jones	Insider	Sell	390	$11.32	$4,414.80	59,610
3/20/2023	Jeffrey Trigilio	CFO	Sell	399	$11.32	$4,516.68	88,003
11/25/2022	Jennifer Michaelson	Insider	Sell	4,000	$13.30	$53,200.00	53,031
9/27/2022	Jennifer Michaelson	Insider	Sell	4,000	$12.40	$49,600.00	53,031
8/4/2022	Vision Scs F2	Major Shareholder	Sell	25,989	$14.31	$371,902.59	1,255,963
8/2/2022	Vision Scs F2	Major Shareholder	Sell	4,792	$14.10	$67,567.20	1,301,081
7/25/2022	Jennifer Michaelson	Insider	Sell	8,000	$14.51	$116,080.00	53,031
7/18/2022	Corrine Savill	Insider	Sell	5,042	$15.06	$75,932.52	164,573
7/11/2022	Corrine Savill	Insider	Sell	40,000	$13.33	$533,200.00	169,615
6/23/2022	Bioscience I 2017 Ltd F2	Major Shareholder	Sell	29,631	$13.00	$385,203.00	537,392
6/21/2022	Bioscience I 2017 Ltd F2	Major Shareholder	Sell	22,319	$12.77	$285,013.63	616,976
6/6/2022	Nadim Ahmed	CEO	Buy	8,090	$12.40	$100,316.00	8,090
6/1/2022	Bvf Partners L P/Il	Major Shareholder	Buy	751,396	$11.00	$8,265,356.00	4,058,854
5/16/2022	Vision Scs F2	Major Shareholder	Sell	35,158	$11.23	$394,824.34	1,305,873
5/12/2022	Vision Scs F2	Major Shareholder	Sell	264,072	$9.25	$2,442,666.00	1,460,539
4/1/2022	Bvf Partners L P/Il	Major Shareholder	Buy	276,000	$10.75	$2,967,000.00	301,671

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

SEC Filings (Institutional Ownership Changes) for Cullinan Therapeutics (NASDAQ:CGEM)

86.31% of Cullinan Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cullinan Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	2,191,262	$35.56M	0.0%	-10.3%	3.763%
11/16/2024	Geode Capital Management LLC	1,208,421	$20.23M	0.0%	+23.8%	2.075%
11/15/2024	Barclays PLC	248,614	$4.16M	0.0%	+26.0%	0.427%
11/15/2024	Y Intercept Hong Kong Ltd	25,369	$0.43M	0.0%	+40.7%	0.044%
11/15/2024	Wellington Management Group LLP	106,025	$1.78M	0.0%	+47.1%	0.182%
11/15/2024	Sphera Funds Management LTD.	185,871	$3.11M	0.5%	N/A	0.319%
11/15/2024	State Street Corp	2,337,222	$39.13M	0.0%	+20.4%	4.014%
11/15/2024	RTW Investments LP	1,705,960	$28.56M	0.4%	+62.1%	2.930%
11/15/2024	Patient Square Capital LP	824,705	$13.81M	5.1%	N/A	1.416%
11/15/2024	HighVista Strategies LLC	31,893	$0.53M	0.2%	N/A	0.055%
11/15/2024	Holocene Advisors LP	1,533,579	$25.67M	0.1%	+16.5%	2.634%
11/14/2024	PFM Health Sciences LP	182,810	$3.06M	0.2%	-38.2%	0.314%
11/14/2024	Braidwell LP	1,176,173	$19.69M	0.6%	+567.6%	2.020%
11/14/2024	Verition Fund Management LLC	36,624	$0.61M	0.0%	N/A	0.063%
11/14/2024	Walleye Capital LLC	328,417	$5.50M	0.0%	+253.6%	0.564%
11/14/2024	Martingale Asset Management L P	32,842	$0.55M	0.0%	+134.2%	0.056%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	70,911	$1.19M	0.0%	+3.5%	0.122%
11/14/2024	MetLife Investment Management LLC	29,841	$0.50M	0.0%	+31.3%	0.051%
11/13/2024	FMR LLC	20,360	$0.34M	0.0%	+2,898.5%	0.035%
11/13/2024	The Manufacturers Life Insurance Company	25,538	$0.43M	0.0%	+68.3%	0.044%
11/12/2024	Charles Schwab Investment Management Inc.	423,959	$7.10M	0.0%	+14.4%	0.731%
11/9/2024	Intech Investment Management LLC	17,487	$0.29M	0.0%	N/A	0.030%
11/7/2024	Quest Partners LLC	20,404	$0.34M	0.0%	+900.7%	0.035%
10/30/2024	Amalgamated Bank	1,768	$30K	0.0%	+97.3%	0.003%
10/29/2024	Harbor Capital Advisors Inc.	21,362	$0.36M	0.0%	+22.2%	0.037%
10/25/2024	China Universal Asset Management Co. Ltd.	11,151	$0.19M	0.0%	+64.7%	0.019%
10/23/2024	Assenagon Asset Management S.A.	135,036	$2.26M	0.0%	+18.3%	0.234%
10/10/2024	Exchange Traded Concepts LLC	9,891	$0.17M	0.0%	-23.0%	0.017%
10/3/2024	SG Americas Securities LLC	15,057	$0.25M	0.0%	-82.3%	0.026%
8/16/2024	Perceptive Advisors LLC	749,916	$13.08M	0.3%	N/A	1.301%
8/16/2024	Algert Global LLC	39,884	$0.70M	0.0%	-49.9%	0.069%
8/15/2024	Blue Owl Capital Holdings LP	2,049,172	$35.74M	10.0%	-29.9%	3.555%
8/15/2024	Lynx1 Capital Management LP	377,323	$6.58M	2.4%	N/A	0.655%
8/15/2024	The Manufacturers Life Insurance Company	15,175	$0.27M	0.0%	+40.7%	0.026%
8/15/2024	Deerfield Management Company L.P. Series C	3,280,237	$57.21M	1.0%	+188.1%	5.691%
8/15/2024	Affinity Asset Advisors LLC	263,817	$4.60M	0.5%	+2.0%	0.458%
8/14/2024	Squarepoint Ops LLC	10,669	$0.19M	0.0%	N/A	0.019%
8/14/2024	Marshall Wace LLP	1,184,037	$20.65M	0.0%	+2,416.9%	2.054%
8/14/2024	Profund Advisors LLC	19,352	$0.34M	0.0%	+26.8%	0.034%
8/13/2024	Ensign Peak Advisors Inc	148,773	$2.60M	0.0%	N/A	0.258%
8/12/2024	E Fund Management Co. Ltd.	74,827	$1.31M	0.1%	N/A	0.130%
8/9/2024	Renaissance Technologies LLC	421,708	$7.36M	0.0%	+31.3%	0.732%
8/9/2024	Dimensional Fund Advisors LP	759,760	$13.25M	0.0%	-23.5%	1.318%
8/8/2024	Cornercap Investment Counsel Inc.	11,491	$0.20M	0.0%	-38.2%	0.020%
8/8/2024	American Century Companies Inc.	76,018	$1.33M	0.0%	+32.9%	0.132%
8/6/2024	Quest Partners LLC	2,039	$36K	0.0%	-76.5%	0.004%
8/5/2024	Arizona State Retirement System	10,460	$0.18M	0.0%	N/A	0.018%
8/1/2024	Rhumbline Advisers	54,351	$0.95M	0.0%	+16.4%	0.094%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,883	$0.16M	0.0%	+73.3%	0.015%
7/26/2024	Bank of New York Mellon Corp	137,997	$2.41M	0.0%	+46.4%	0.239%
7/18/2024	Assenagon Asset Management S.A.	114,195	$1.99M	0.0%	N/A	0.198%
7/12/2024	SG Americas Securities LLC	85,172	$1.49M	0.0%	+757.2%	0.148%
7/9/2024	Harbor Capital Advisors Inc.	17,481	$0.31M	0.0%	+39.4%	0.030%
5/16/2024	California State Teachers Retirement System	23,752	$0.41M	0.0%	-5.7%	0.055%
5/16/2024	Kennedy Capital Management LLC	84,234	$1.44M	0.0%	-47.4%	0.196%
5/15/2024	Price T Rowe Associates Inc. MD	22,842	$0.39M	0.0%	+3.7%	0.053%
5/15/2024	Affinity Asset Advisors LLC	258,588	$4.41M	0.6%	-13.8%	0.600%
5/14/2024	American International Group Inc.	12,742	$0.22M	0.0%	-99.0%	0.030%
5/13/2024	Ameritas Investment Partners Inc.	2,599	$44K	0.0%	+31.0%	0.006%
5/10/2024	Vanguard Group Inc.	1,774,345	$30.24M	0.0%	+0.2%	4.120%
5/7/2024	SG Americas Securities LLC	9,936	$0.17M	0.0%	-31.2%	0.023%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	17,269	$0.29M	0.0%	+22.2%	0.040%
4/29/2024	China Universal Asset Management Co. Ltd.	8,996	$0.15M	0.0%	+81.6%	0.021%
2/28/2024	American International Group Inc.	1,236,564	$12.60M	0.1%	+0.1%	2.891%
2/15/2024	Parkman Healthcare Partners LLC	529,877	$5.40M	0.8%	+20.8%	1.239%
2/14/2024	Braidwell LP	1,240,865	$12.64M	0.5%	-35.0%	2.901%
2/13/2024	American International Group Inc.	1,236,564	$12.60M	0.1%	+0.1%	2.891%
2/13/2024	Tower Research Capital LLC TRC	10,234	$0.10M	0.0%	-33.5%	0.024%
2/13/2024	Affinity Asset Advisors LLC	300,000	$3.06M	0.6%	N/A	0.701%
2/13/2024	NEOS Investment Management LLC	15,906	$0.16M	0.0%	N/A	0.037%
2/9/2024	Franklin Resources Inc.	3,281,280	$33.44M	0.0%	+13.5%	7.670%
2/9/2024	Quest Partners LLC	17,601	$0.18M	0.0%	N/A	0.041%
2/9/2024	Trexquant Investment LP	34,955	$0.36M	0.0%	N/A	0.082%
2/6/2024	Swiss National Bank	46,300	$0.47M	0.0%	+19.9%	0.108%
2/6/2024	New York Life Investment Management LLC	33,759	$0.34M	0.0%	-3.0%	0.079%
2/2/2024	Bailard Inc.	10,800	$0.11M	0.0%	N/A	0.025%
1/30/2024	Vontobel Holding Ltd.	10,000	$0.10M	0.0%	N/A	0.023%
1/24/2024	China Universal Asset Management Co. Ltd.	4,954	$50K	0.0%	+352.4%	0.012%
1/12/2024	SG Americas Securities LLC	14,449	$0.15M	0.0%	+12.3%	0.034%
1/5/2024	Exchange Traded Concepts LLC	14,076	$0.14M	0.0%	+34.0%	0.033%
12/6/2023	Citigroup Inc.	23,534	$0.21M	0.0%	+186.1%	0.055%
11/15/2023	Annandale Capital LLC	12,000	$0.11M	0.0%	+20.0%	0.028%
11/15/2023	Kennedy Capital Management LLC	489,446	$4.43M	0.1%	-9.7%	1.144%
11/14/2023	Schonfeld Strategic Advisors LLC	121,800	$1.10M	0.0%	+15.9%	0.285%
11/13/2023	Algert Global LLC	16,540	$0.15M	0.0%	N/A	0.039%
11/13/2023	Federated Hermes Inc.	20,000	$0.18M	0.0%	N/A	0.047%
11/13/2023	Hsbc Holdings PLC	21,875	$0.20M	0.0%	N/A	0.051%
11/8/2023	New York Life Investment Management LLC	34,804	$0.32M	0.0%	-13.6%	0.081%
11/7/2023	Barclays PLC	53,393	$0.48M	0.0%	+145.6%	0.125%
11/6/2023	Assenagon Asset Management S.A.	609,106	$5.51M	0.0%	+380.1%	1.425%
10/27/2023	Allspring Global Investments Holdings LLC	7,095	$64K	0.0%	-61.6%	0.017%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,542	$59K	0.0%	+1,331.5%	0.015%
10/24/2023	Bank of New York Mellon Corp	97,159	$0.88M	0.0%	+11.5%	0.227%
10/20/2023	Harbor Capital Advisors Inc.	10,266	$93K	0.0%	-26.1%	0.024%
10/18/2023	Exchange Traded Concepts LLC	10,507	$95K	0.0%	-9.9%	0.025%
10/13/2023	SG Americas Securities LLC	12,862	$0.12M	0.0%	N/A	0.030%
8/22/2023	CHI Advisors LLC	3,414,189	$36.74M	11.1%	+1.9%	7.988%
8/15/2023	Braidwell LP	1,908,865	$20.54M	0.7%	N/A	4.466%
8/11/2023	SVB Financial Group	13,516	$0.15M	0.3%	-33.3%	0.034%
8/11/2023	Velan Capital Investment Management LP	50,000	$0.54M	0.5%	N/A	0.127%

Data available starting January 2016

Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The company's lead program comprises CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors. Its development portfolio also includes CLN-049, a humanized bispecific antibody that is in Phase I clinical trial for the treatment of acute myeloid leukemia or myelodysplastic syndrome; CLN-418, a human bispecific immune activator that is in Phase 1 clinical trial for the treatment of multiple solid tumors; and Zipalertinib, a bioavailable small-molecule for treating patients with non-small cell lung cancer. In addition, the company's development products comprise CLN-617, a fusion protein for the treatment of solid tumors; and CLN-978, a T cell engaging antibody for the treatment relapsed/refractory B-cell non-Hodgkin lymphoma. It has license and collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; Harbour BioMed US Inc. for the development, manufacturing, and commercialization of CLN-418; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop Zipalertinib. Cullinan Therapeutics, Inc. was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $11.60

$10.78

$11.86

50 Day Range

MA: $14.28

$10.77

$17.61

52 Week Range

Now: $11.60

$8.49

$30.19

Volume

862,713 shs

Average Volume

644,257 shs

Market Capitalization

$675.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cullinan Therapeutics?: Cullinan Therapeutics' top insider investors include:
Corrine Savill (Insider)
Jennifer Michaelson (Insider)
Nadim Ahmed (CEO)
Jeffrey Trigilio (CFO)
Jeffrey Alan Jones (Insider)
Learn More about top insider investors at Cullinan Therapeutics.
Who are the major institutional investors of Cullinan Therapeutics?: Cullinan Therapeutics' top institutional investors include:
State Street Corp — 4.01%
Franklin Resources Inc. — 3.76%
RTW Investments LP — 2.93%
Holocene Advisors LP — 2.63%
Geode Capital Management LLC — 2.08%
Braidwell LP — 2.02%
Learn More about top institutional investors of Cullinan Therapeutics stock.
Which institutional investors are selling Cullinan Therapeutics stock?: During the last quarter, CGEM stock was sold by these institutional investors:
Franklin Resources Inc.
PFM Health Sciences LP
SG Americas Securities LLC
Exchange Traded Concepts LLC
In the last year, company insiders that have sold Cullinan Therapeutics company stock include:
Corrine Savill (Insider)
Jennifer Michaelson (Insider)
Nadim Ahmed (CEO)
Jeffrey Trigilio (CFO)
Jeffrey Alan Jones (Insider)
Learn More investors selling Cullinan Therapeutics stock.
Which institutional investors are buying Cullinan Therapeutics stock?: During the last quarter, CGEM stock was bought by institutional investors including:
Braidwell LP
Patient Square Capital LP
RTW Investments LP
State Street Corp
Walleye Capital LLC
Geode Capital Management LLC
Holocene Advisors LP
Sphera Funds Management LTD.